Login

Jesper Wiklund, CEO, Klaria Pharma Holding AB (publ) 00:00:00

Share On Facebook Share On Twitter

Klaria Pharma Holding AB (publ)

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Supporting Vulnerable Households: A Conversation on Energy Assistance Programs and Advocacy | Chris O'Shea, CEO,Centrica PLC.
00:10:00
Invests in the people products and processes that power commerce|Aubrie Pagano,General Partner,Alpaca VC
00:10:00
Discover the Culture at Wilson Sonsini | Lori P. Westin - PARTNER of Wilson Sonsini
00:10:00
India is an Opportunity & Trends|Sameer Gandhi,Investor, Accel
00:10:00
Azure Minerals focuses on nickel, copper, and gold projects in Western Australia
00:10:00
UBS Wealth Management Strategy: Beyond Disruption | Jason Chandler - Head of Wealth Management at UBS Financial Services
00:10:00
Tia Borden interviews Keith Henderson, President, CEO & Director of Latin Metals Inc., at Resourcing Tomorrow event in London, discussing Latin Metals' projects and initiatives.|Keith Henderson, President, CEO & Director of Latin Metals Inc
00:10:00
Uganda's Energy Evolution: A Conversation with a Managing Director| Selestino Babungi, CEO , Umeme Ltd.
00:10:00
Leading Barclays Through Turbulent Times: The Stewardship of C.S. Venkatakrishnan | C.S. Venkatakrishnan , CEO , Barclays.
00:10:00
Templeton Global Balanced Fund: A Strategic Approach to Diversified Investing | Jane Doe, Portfolio Manager, Templeton Global Balanced Fund, Franklin Templeton Investments
00:10:00
The Doro Q1 2020 report highlights a 20.6% decrease in net sales to SEK 336.7 million, with a strong gross margin improvement to 37.7%|Jörgen Nilsson is President & CEO doro
00:10:00
Midas Gold's Stibnite Gold Project: Reimagining Idaho Mining with Large-Scale Open Pit Operations

© 2026 Nehu